Sitemap

?g

Whole Genome Sequencing

WGS

Wash out period

Vulnerable participants or populations

Vector

Validity

Vaccine

Utility

USPI

Universal Declaration of Human Rights

Unique Device Identification

Unexpected Adverse Reaction

UDI

UAE

Type II Error

Type I Error

T-test

TTE

Trial arm

Treatment group

Treatment Emergent Adverse Event

Translated

Transgenic

Transfusion

Transdermal

Transcriptome

Transcribed

TQTc

TPP

Toxoid vaccine

Toxicology

Toxicokinetics

Toxicity

Tolerability

Time-to-event endpoint

Therapeutic vaccines

Therapeutic indication

Therapeutic Alternatives

Thalidomide

TEAE

Targeted medicine

Target Product Profile

Target patient population

Systemic toxicology

Symptom

Suspected Unexpected Serious Adverse Reaction

SUSAR

Surrogate endpoint

Summary of Product Characteristics

Subunit vaccine

Subpopulation

Submission

Sublingual

Subcutaneous

Study Population

Study medication

Stratified medicine

Stratification

Stent

Stem Cells

Stem Cell Therapy

Statistics

Statistical Significance

Statistical Inference

Statistical analysis plan

Standard Deviation

Stability

Sponsor

Specificity

Somatic-cell therapy medicine

Somatic Cell Nuclear Transfer

Somatic

Solubility

Soft Endpoint

SmPC

Site visit

siRNA

Single ascending dose study

Silencing

Significance Level

Significance

Signalling Pathway

Sign

Side Effect

Serious Adverse Reaction

Serious Adverse Event

Sensitivity

Selective Reporting

Selection Bias

SCNT

Scientific Advisory Group

Scientific Advice Working Party

Scale-up

SAWP

SAR

SAP

Sample size

SAG

Safety specification

Safety Pharmacology

SAE

SAD

Routine pharmacovigilance activities

RMP

Risk minimisation measures

Risk Management Plan

Risk management

Risk factor

Risk Evaluation and Mitigation Strategy

Risk assessment

Risk

Rigour

Retrospective Case Control Study

Response Variable

Respect for persons

Repurposing

Reproductive Toxicology

REMS

Remission

Reliability

Relative efficacy

Relative clinical effectiveness

Reimbursement

Regulatory affairs

Reference medicine

Recurrence

Recruitment

Recombinant vaccine

Recombinant Gene

Recombinant DNA

Reassortant vaccine

rDNA

RCT

Rare disease

Randomised participants

Randomised controlled trial

Randomised clinical trial

Randomisation

Quasi-randomised trial

Quantitative Study

Quality-adjusted life year

Quality of Life

Quality Control

Qualitative Study

QoL

QC

QALY

P-value

Publication Bias

1 2 3 … 1,552 Next »